EcoDrugPlus

Cannabinoid Receptor 2

Ensembl ID : ENSUAMG00000008907
Gene Symbol: CNR2
2 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 1

Ensembl ID : ENSUAMG00000011581
Gene Symbol: CA1
2 Cross references
285 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSUAMG00000013380
Gene Symbol: CA12
2 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 13

Ensembl ID : ENSUAMG00000018933
Gene Symbol: CA13
2 Cross references
288 Possible Orthologues:

Carbonic Anhydrase 14

Ensembl ID : ENSUAMG00000009329
Gene Symbol: CA14
2 Cross references
210 Possible Orthologues:

Carbonic Anhydrase 2

Ensembl ID : ENSUAMG00000009776
Gene Symbol: CA2
2 Cross references
282 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSUAMG00000009777
Gene Symbol: CA3
2 Cross references
307 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSUAMG00000023179
Gene Symbol: CA4
2 Cross references
267 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSUAMG00000006211
Gene Symbol: CA5A
2 Cross references
167 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSUAMG00000024087
Gene Symbol: CA6
1 Cross references
218 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSUAMG00000006657
Gene Symbol: CA7
2 Cross references
220 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSUAMG00000025218
Gene Symbol: CA9
2 Cross references
280 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).